{
    "2021-04-30": [
        [
            {
                "time": "",
                "orginal_text": "再谈创新药指数指数投资价值分析",
                "features": {
                    "keywords": [
                        "创新药",
                        "指数",
                        "投资价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "副业超主业，“基层市场器械之王”乐普拆分医药上市，但主业地盘就被攻进来",
                "features": {
                    "keywords": [
                        "乐普",
                        "拆分",
                        "医药",
                        "上市",
                        "主业",
                        "器械"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "场外资金坐不住了：医疗器械板块不是业绩超预期就是股价创新高",
                "features": {
                    "keywords": [
                        "场外资金",
                        "医疗器械",
                        "业绩",
                        "股价",
                        "创新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "新股前瞻丨押注热门靶点，乐普生物能否借PD-1出圈？",
                "features": {
                    "keywords": [
                        "新股",
                        "乐普生物",
                        "PD-1",
                        "热门靶点"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "2021年，这些药企更受资本青睐！",
                "features": {
                    "keywords": [
                        "2021年",
                        "药企",
                        "资本",
                        "青睐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "A股收盘：创业板指为何逆势涨超1%？生物医药股霸占大半周线前十成分股",
                "features": {
                    "keywords": [
                        "A股",
                        "收盘",
                        "创业板指",
                        "生物医药",
                        "逆势上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "北上资金加仓多只绩优疫苗股，9股增持超亿",
                "features": {
                    "keywords": [
                        "北上资金",
                        "加仓",
                        "疫苗",
                        "绩优股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
                "features": {
                    "keywords": [
                        "海外疫情",
                        "Q1业绩",
                        "疫苗",
                        "新冠检测",
                        "资金加仓"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗",
                        "检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "械“小阳春”渐入佳境，市场首只医疗器械ETF上市迎“开门红”",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "ETF",
                        "小阳春",
                        "开门红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "乐普医疗拆分公司乐普生物港交所递表",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "拆分",
                        "乐普生物",
                        "港交所",
                        "递表"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
                "features": {
                    "keywords": [
                        "白酒",
                        "跌停",
                        "郭广昌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "乐普医疗：集采影响逐步消退期待创新器械产品",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "集采",
                        "创新器械",
                        "影响消退"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}